文献速递鼻科小儿耳鼻咽喉

复发性急性鼻窦炎中免疫缺陷的评估与检查:范围综述

Evaluation and workup of immunodeficiencies in recurrent acute rhinosinusitis: A scoping review.
PubMed 文献 · Int Forum Allergy Rhinol · 2022-11-27

本范围综述按PRISMA-ScR指南检索PubMed、Web of Science和CINAHL,从209篇文献中纳入11篇,分析复发性急性鼻窦炎(RARS)患者免疫缺陷评估的现有文献。多数文章推荐进行免疫缺陷检测,包括定量免疫球蛋白、疫苗接种后抗体滴度和IgG亚类检测,但RARS定义和推荐人群差异很大。作者认为缺乏针对RARS患者免疫缺陷诊断检查的循证文章,需采用标准化定义并聚焦RARS的进一步研究。

要点

  • 11篇纳入文献中10篇推荐对RARS患者进行免疫缺陷检测。
  • 推荐检测以定量免疫球蛋白(6篇)和疫苗接种后抗体滴度(5篇)为主。
  • 8篇给出时机推荐的文章中6篇建议在反复感染或诊断后检测。

核心结论

  • 现有RARS文献强调在诊断后通过免疫球蛋白定量和疫苗接种后抗体滴度评估原发性免疫缺陷病(PIDD)。
  • 推荐受目标人群广泛和定义不一致限制,缺乏针对RARS患者PIDD诊断检查的循证文章。
  • 作者认为需要采用标准化定义并聚焦RARS的进一步研究来指导临床实践。

研究设计与样本

  • 范围综述,按PRISMA-ScR指南进行,由两名评审员系统评估 eligibility。
  • 从PubMed、Web of Science和CINAHL检索复发性急性鼻窦炎与免疫缺陷相关文章,209篇独特文献中11篇符合分析与纳入标准。
  • 纳入文章包括历史队列研究、病例对照研究、横断面研究,以及病例系列和非系统综述。

主要发现

  • 11篇纳入文章中10篇推荐免疫缺陷检测,包括一般免疫筛查(3篇)、定量免疫球蛋白(6篇)和疫苗接种后抗体滴度(5篇)。
  • 文章强调免疫球蛋白G(IgG)亚类检测(6篇)。
  • 8篇提供时机推荐的文章中6篇推荐在反复感染或诊断后检测,但RARS诊断标准和推荐目标人群在各文章间差异很大。

关键数值与推荐

  • 10篇推荐免疫缺陷检测的文章中,推荐一般免疫筛查3篇、定量免疫球蛋白6篇、疫苗接种后抗体滴度5篇。
  • 6篇文章强调IgG亚类检测。
  • 8篇提供时机推荐的文章中6篇推荐在反复感染或诊断后检测。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 推荐受目标人群广泛和定义不一致限制。
  • 缺乏针对RARS患者PIDD诊断检查的循证文章。
  • 作者认为需要采用标准化定义并聚焦RARS的进一步研究来指导临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary immunodeficiency disorders (PIDDs) may be a risk factor for development of recurrent acute rhinosinusitis (RARS). There are currently no clear guidelines for the timing and methodology of PIDD testing in patients with RARS. The aim of this scoping review is to identify and analyze existing literature on this topic. METHODS: A scoping review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines. Articles addressing recurrent acute sinusitis and immunodeficiencies were collected from PubMed, Web of Science, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and systematically evaluated for eligibility by two reviewers. RESULTS: Of the 209 unique articles identified, 11 met criteria for review and analysis. Articles consisted of historical cohort, case-control, and cross-sectional studies, in addition to case series and nonsystematic reviews. The majority (10) recommended immunodeficiency testing, consisting of general immunologic screening (3), quantitative immunoglobulins (6), and postvaccination antibody titers (5). There was an emphasis on immunoglobulin G (IgG) subclass testing (6). Of the eight articles providing timing recommendations, the majority recommended testing after recurrent infections or diagnosis (6); however, criteria for diagnosis of RARS and populations targeted by recommendations varied greatly by article. CONCLUSION: Current literature on RARS emphasizes immunoglobulin quantification and postvaccination antibody titers to evaluate for PIDD after diagnosis, but recommendations are limited by wide-ranging populations of interest and inconsistent definitions. This scoping review identified a lack of evidence-based articles specific to diagnostic workup for PIDD in patients with RARS, and additional research with standardized definitions and focus on RARS is necessary to guide clinical practice.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Mandava S, Lin J, Joshua C, et al. Evaluation and workup of immunodeficiencies in recurrent acute rhinosinusitis: A scoping review. Int Forum Allergy Rhinol. 2022. PMID: 36355381. doi:10.1002/alr.23106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。